Company Filing History:
Years Active: 1978-1981
Title: The Innovations of Erik Yngve Holmer
Introduction
Erik Yngve Holmer is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heparin fragments with selective anticoagulation activity. His work has led to the filing of two patents that showcase his innovative approach to medical science.
Latest Patents
Holmer's latest patents include "Heparin fragments having selective anticoagulation activity" and "Heparin purification method." The first patent focuses on heparin fragments that contain 14-18 sugar units, with a specific disaccharide unit being the main component. This invention aims to enhance the anticoagulation properties of heparin. The second patent describes a method for purifying crude clinically used heparin preparations, which involves using a gel matrix complexed with heparin-binding plasma proteins. This method improves the quality of heparin by removing impurities and enhancing its efficacy.
Career Highlights
Throughout his career, Holmer has worked with prominent companies such as Kabi AB and Ab Kabi. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Holmer has collaborated with notable professionals in his field, including Lars-Olov Andersson and Ulf P Lindahl. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Erik Yngve Holmer's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to influence the development of anticoagulant therapies, showcasing the importance of innovation in healthcare.